The Muscular Dystrophy Association to Host Virtual Events to Raise Funds for RX and Care of People with MD, ALS and Related Neuromuscular Disease

The Muscular Dystrophy Association (is hosting virtual events to raise critical funds for treatment and care for people affected by muscular dystrophy, ALS, and related neuromuscular disease. September marks “MDA National Muscular Dystrophy Awareness Month,” an annual observance that raises awareness for more than 250,000 families across the nation who are living with neuromuscular disease.

The Muscular Dystrophy Association historic fundraisers, including MDA Muscle Walk and the Harley-Davidson MDA Ride for Life, will be hosted virtually for the first time – expanding opportunities for participation while supporting social distancing and safety for the neuromuscular disease community who are at high risk for COVID-19.

“Labor Day Weekend has always been an incredibly important fundraising time for MDA and now, during the pandemic it is more critical than ever for our vulnerable community,” said Lynn O’Connor Vos, President, and CEO of MDA. “COVID-19 won’t stop us as we embrace virtual events for our MDA Muscle Walks, our long-standing Harley-Davidson Ride for Strength, our IAFF Fill the Boot program, and our fall galas. We will continue to raise awareness for muscular dystrophy, ALS, and related neuromuscular diseases so we can fund the research and care to find cures.”

To learn more about any of these events, please visit here.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version